Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pieper

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
The American Journal of Cardiology|May 30, 1998
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary ArteriesJ Hochrein, F Sun, K S Pieper, et al.
BMJ (Clinical Research Ed.)|October 13, 2006
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)Keith A A Fox, Omar H Dabbous, Robert J Goldberg, et al.
BMJ (Clinical Research Ed.)|October 28, 2021
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry dataMarita Knudsen Pope, Trygve S Hall, Valentina Schirripa, et al.
Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
JACC. Cardiovascular Interventions|July 21, 2012
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomesAdriano A M Truffa, Christopher B Granger, Kyle R White, et al.
European Heart Journal|March 13, 2008
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIbRajendra H Mehta, Sunil V Rao, E Magnus Ohman, et al.
Heart Rhythm|March 8, 2007
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experienceKent Stephenson, Hicham Skali, John J V McMurray, et al.
The American Journal of Cardiology|January 31, 2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)Melvin R Echols, Kenneth W Mahaffey, Anindita Banerjee, et al.
The American Journal of Medicine|December 29, 2010
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic TherapyRajendra H Mehta, Amanda Stebbins, Renato D Lopes, et al.
Journal of the American College of Cardiology|February 21, 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
The American Journal of Cardiology|May 30, 1998
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary ArteriesJ Hochrein, F Sun, K S Pieper, et al.
BMJ (Clinical Research Ed.)|October 13, 2006
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)Keith A A Fox, Omar H Dabbous, Robert J Goldberg, et al.
BMJ (Clinical Research Ed.)|October 28, 2021
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry dataMarita Knudsen Pope, Trygve S Hall, Valentina Schirripa, et al.
Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
JACC. Cardiovascular Interventions|July 21, 2012
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomesAdriano A M Truffa, Christopher B Granger, Kyle R White, et al.
European Heart Journal|March 13, 2008
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIbRajendra H Mehta, Sunil V Rao, E Magnus Ohman, et al.
Heart Rhythm|March 8, 2007
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experienceKent Stephenson, Hicham Skali, John J V McMurray, et al.
The American Journal of Cardiology|January 31, 2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)Melvin R Echols, Kenneth W Mahaffey, Anindita Banerjee, et al.
The American Journal of Medicine|December 29, 2010
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic TherapyRajendra H Mehta, Amanda Stebbins, Renato D Lopes, et al.
Journal of the American College of Cardiology|February 21, 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.
Pageof 23